henry semaglutide 5728324 Henry Meds: Why Patients Choose
Description
Even with this relatively limited assessment of signaling, quantitative evidence for peptide-mediated signal bias was observed, with oxyntomodulin exhibiting a relative bias toward pERK over cAMP and iCa 2+ signaling compared with either GLP-1 or exendin (Koole et al., 2010), and this supported earlier observations of differences in cAMP signaling and -arrestin recruitment between oxyntomodulin and GLP-1 736 amide (Jorgensen et al., 2007)

However, avoid prolonged use without speaking to your healthcare provider first

According to results published in NEJM, Mounjaro achieved A1C reductions of 2.01% (5mg), 2.24% (10mg), and 2.30% (15mg) versus 1.86% with semaglutide 1mg

There should definitely be follow-ups on your metabolic labs, um, on your, uh, InBody analysis, your DEXA scans

However, like all medications, GLP-1 drugs carry risks

RCT supports the rare occurrence of thyroid cancer diagnosis during relatively short follow-up periods, and without conclusive evidence of increased risk of thyroid cancer in GLP-1 RA users
